{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:50:05Z","timestamp":1773697805172,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ijom.2006.02.022","type":"journal-article","created":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T11:19:30Z","timestamp":1147346370000},"page":"588-593","source":"Crossref","is-referenced-by-count":78,"title":["Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases"],"prefix":"10.1016","volume":"35","author":[{"given":"I.","family":"Dimitrakopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Magopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Karakasis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2006.02.022_bib1","article-title":"Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases","author":"Bagan","year":"2005","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2006.02.022_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.142.2.573","article-title":"Integrin-mediated signals regulated by members of the rho family of GTPases","volume":"142","author":"Clark","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ijom.2006.02.022_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0026-895X(24)13063-5","article-title":"Protein geranylgeranylation is required for caspase activation and induction of apoptosis by bisphosphonate drugs","volume":"54","author":"Coxon","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijom.2006.02.022_bib4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","article-title":"Esophagitis associated with the use of aledronate","volume":"335","author":"De Groen","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijom.2006.02.022_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure activity relationships for inhibition of farnesyl diphosphonate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.ijom.2006.02.022_bib6","first-page":"233","article-title":"Mechanisms of action of etidronate and other bisphosphonates","volume":"9","author":"Ebetino","year":"1998","journal-title":"Rev Contemp Pharmacother"},{"key":"10.1016\/j.ijom.2006.02.022_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","article-title":"Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment","volume":"32","author":"Ficara","year":"2005","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.ijom.2006.02.022_bib8","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1210\/en.141.12.4793","article-title":"In vivo effects of bisphosphonates on the osteoclast mevalonate pathway","volume":"141","author":"Fisher","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijom.2006.02.022_bib9","first-page":"1361","article-title":"Bisphosphonates\u2014Mechanism of Action","volume":"Vol. II","author":"Fleisch","year":"2002"},{"key":"10.1016\/j.ijom.2006.02.022_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cytogfr.2004.04.003","article-title":"Constitutive and inducible expression and regulation of vascular endothelial growth factor","volume":"15","author":"Keping","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ijom.2006.02.022_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jcms.2005.07.007","article-title":"Does avascular necrosis of jaws in cancer patients only occur following treatment with bisphosphonates?","volume":"33","author":"Lenz","year":"2005","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijom.2006.02.022_bib12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ijom.2006.02.022_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (AREDIA) and Zoledronate (ZOMETA) induced avascular Necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2006.02.022_bib14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate- induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2006.02.022_bib15","series-title":"Oral and Maxillo-Facial Pathology: A Rationale for Diagnosis and Treatment","author":"Marx","year":"2003"},{"key":"10.1016\/j.ijom.2006.02.022_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/IR:23:2-3:263","article-title":"VEGF as a mediator of tumor-associated immunodeficiency","volume":"23","author":"Ohm","year":"2001","journal-title":"Immunol Res"},{"key":"10.1016\/j.ijom.2006.02.022_bib17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrc925","article-title":"Vascular and haematopoietic stem cells: novel target for anti-angiogenesis therapy?","volume":"2","author":"Rafii","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijom.2006.02.022_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.59.2.193","article-title":"Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in keratinocyte model for esophageal irritation","volume":"59","author":"Reszka","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"Suppl.","key":"10.1016\/j.ijom.2006.02.022_bib19","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ijom.2006.02.022_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2006.02.022_bib21","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijom.2006.02.022_bib22","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Aledronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijom.2006.02.022_bib23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.joms.2005.06.003","article-title":"Bisphosphonate-associated osteonecrosis of the jaws","volume":"63","author":"Schwartz","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2006.02.022_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijom.2006.02.022_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00001813-200501000-00002","article-title":"Preclinical evidence for the effects of bisphosphonates and cytotoxic drugs on tumor cell invasion","volume":"16","author":"Woodward","year":"2005","journal-title":"Anticancer Drugs"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150270600138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150270600138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T22:28:48Z","timestamp":1736375328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S090150270600138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S090150270600138X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2006.02.022","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}